Artificial intelligence applications continue to make strides across biotech fields. Tahoe Therapeutics raised $30 million to build large-scale AI models of human cells for drug discovery. Deephealth acquired Icad and gained FDA clearance for remote imaging software. AI-driven tools improve radiomics-based chemo prediction in breast cancer and voice analysis for early cancer detection. Meanwhile, challenges concerning AI’s medical information accuracy and ethical implementation highlight the need for cautious integration.